Trial
NCT01174199
Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
Merck Sharp & Dohme LLC
Condition
Prostate Cancer
Intervention
vorinostat
Why stopped
no value in finding efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-03